Strengths of the current analyzes are the presence of many longitudinal, serially taken plasma samples per patient that could be interrogated with targeted NGS for putative reversions, allowing survival modeling, and the use of ctDNA WGS to interrogate BRCA2 clonality and subsequent correlations with orthogonal methods using CTCs and tumor biopsies. Here, BRCA2 is linked to neoplasm.